ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities.

IF 4.2 3区医学 Q1 SUBSTANCE ABUSE

Journal of Addiction Medicine Pub Date : 2025-07-01 DOI:10.1097/ADM.0000000000001494

Javier Ballester, Dawn Lindsay, Kevin Simon, Lara Weinstein, Stephanie Weiss, Ray Denny, Daniel Ciccarone

引用次数: 0

Abstract

This commentary highlights significant research gaps identified during the creation of the ASAM/AAAP Clinical Practice Guideline (CPG) on the Management of Stimulant Use Disorder (StUD). These included further research into the implementation of contingency management for StUD, pharmacotherapy options for StUD, evaluation and treatment of stimulant-induced psychosis, harm reduction techniques, and better defining a stimulant overdose. Further research concerning other populations impacted by stimulant use, including adolescents, pregnant and incarcerated individuals, and minoritized populations, is also urgently needed.

查看原文本刊更多论文

ASAM/AAAP兴奋剂使用障碍（StUD）管理临床实践指南（CPG）：对研究重点的评论。

这篇评论强调了在ASAM/AAAP关于兴奋剂使用障碍（StUD）管理的临床实践指南（CPG）的创建过程中发现的重大研究差距。其中包括进一步研究StUD应急管理的实施，StUD的药物治疗方案，兴奋剂诱发精神病的评估和治疗，减少危害的技术，以及更好地定义兴奋剂过量。还迫切需要进一步研究受兴奋剂使用影响的其他人群，包括青少年、孕妇和被监禁者以及少数群体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Addiction Medicine 医学-药物滥用

CiteScore

6.10

自引率

9.10%

发文量

260

审稿时长

>12 weeks

期刊介绍： The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including: •addiction and substance use in pregnancy •adolescent addiction and at-risk use •the drug-exposed neonate •pharmacology •all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances •diagnosis •neuroimaging techniques •treatment of special populations •treatment, early intervention and prevention of alcohol and drug use disorders •methodological issues in addiction research •pain and addiction, prescription drug use disorder •co-occurring addiction, medical and psychiatric disorders •pathological gambling disorder, sexual and other behavioral addictions •pathophysiology of addiction •behavioral and pharmacological treatments •issues in graduate medical education •recovery •health services delivery •ethical, legal and liability issues in addiction medicine practice •drug testing •self- and mutual-help.